ArticleClinical cardiology2022

Comment on: Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta-analysis.

Jian-Hao Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.